Psychemedics Corporation (PMD)
USD 2.67
(0.0%)
USD 2.67
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 22.09 Million USD | -12.45% |
| 2022 | 25.24 Million USD | 1.33% |
| 2021 | 24.9 Million USD | 16.62% |
| 2020 | 21.36 Million USD | -43.31% |
| 2019 | 37.67 Million USD | -11.71% |
| 2018 | 42.67 Million USD | 7.49% |
| 2017 | 39.7 Million USD | 1.85% |
| 2016 | 38.98 Million USD | 44.5% |
| 2015 | 26.97 Million USD | -7.63% |
| 2014 | 29.2 Million USD | 8.69% |
| 2013 | 26.87 Million USD | 6.53% |
| 2012 | 25.22 Million USD | 4.71% |
| 2011 | 24.08 Million USD | 19.8% |
| 2010 | 20.1 Million USD | 18.6% |
| 2009 | 16.95 Million USD | -26.12% |
| 2008 | 22.94 Million USD | -6.59% |
| 2007 | 24.56 Million USD | 4.88% |
| 2006 | 23.42 Million USD | 9.52% |
| 2005 | 21.38 Million USD | 12.94% |
| 2004 | 18.93 Million USD | 18.39% |
| 2003 | 15.99 Million USD | -0.45% |
| 2002 | 16.06 Million USD | 2.15% |
| 2001 | 15.73 Million USD | -18.16% |
| 2000 | 19.21 Million USD | -1.94% |
| 1999 | 19.6 Million USD | 10.73% |
| 1998 | 17.7 Million USD | 14.94% |
| 1997 | 15.4 Million USD | 26.23% |
| 1996 | 12.2 Million USD | 20.79% |
| 1995 | 10.1 Million USD | 16.09% |
| 1994 | 8.7 Million USD | 31.82% |
| 1993 | 6.6 Million USD | 65.0% |
| 1992 | 4 Million USD | 60.0% |
| 1991 | 2.5 Million USD | 47.06% |
| 1990 | 1.7 Million USD | 466.67% |
| 1989 | 300 Thousand USD | 200.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 5.35 Million USD | 7.18% |
| 2024 Q2 | 4.72 Million USD | -11.74% |
| 2023 Q4 | 4.99 Million USD | -12.38% |
| 2023 Q2 | 5.53 Million USD | -5.5% |
| 2023 Q1 | 5.85 Million USD | 2.74% |
| 2023 Q3 | 5.7 Million USD | 3.02% |
| 2023 FY | 22.09 Million USD | -12.45% |
| 2022 Q3 | 6.51 Million USD | 0.05% |
| 2022 Q1 | 6.5 Million USD | 1.12% |
| 2022 Q2 | 6.51 Million USD | 0.08% |
| 2022 Q4 | 5.7 Million USD | -12.48% |
| 2022 FY | 25.24 Million USD | 1.33% |
| 2021 Q4 | 6.43 Million USD | -3.55% |
| 2021 Q2 | 6.08 Million USD | 6.55% |
| 2021 Q3 | 6.67 Million USD | 9.63% |
| 2021 FY | 24.9 Million USD | 16.62% |
| 2021 Q1 | 5.71 Million USD | 7.09% |
| 2020 FY | 21.36 Million USD | -43.31% |
| 2020 Q4 | 5.33 Million USD | 3.11% |
| 2020 Q3 | 5.17 Million USD | 56.13% |
| 2020 Q2 | 3.31 Million USD | -56.03% |
| 2020 Q1 | 7.53 Million USD | -13.52% |
| 2019 FY | 37.67 Million USD | -11.71% |
| 2019 Q2 | 9.28 Million USD | -5.43% |
| 2019 Q3 | 9.85 Million USD | 6.06% |
| 2019 Q4 | 8.71 Million USD | -11.54% |
| 2019 Q1 | 9.82 Million USD | -1.15% |
| 2018 FY | 42.67 Million USD | 7.49% |
| 2018 Q2 | 10.78 Million USD | -1.35% |
| 2018 Q1 | 10.93 Million USD | 12.04% |
| 2018 Q3 | 11.01 Million USD | 2.12% |
| 2018 Q4 | 9.93 Million USD | -9.8% |
| 2017 FY | 39.7 Million USD | 1.85% |
| 2017 Q4 | 9.76 Million USD | -2.88% |
| 2017 Q1 | 10.2 Million USD | -5.16% |
| 2017 Q2 | 9.68 Million USD | -5.14% |
| 2017 Q3 | 10.04 Million USD | 3.77% |
| 2016 Q4 | 10.76 Million USD | -9.16% |
| 2016 FY | 38.98 Million USD | 44.5% |
| 2016 Q3 | 11.84 Million USD | 22.16% |
| 2016 Q2 | 9.7 Million USD | 45.49% |
| 2016 Q1 | 6.66 Million USD | 8.69% |
| 2015 Q2 | 7 Million USD | 3.64% |
| 2015 Q1 | 6.75 Million USD | -0.09% |
| 2015 FY | 26.97 Million USD | -7.63% |
| 2015 Q3 | 7.08 Million USD | 1.18% |
| 2015 Q4 | 6.13 Million USD | -13.41% |
| 2014 FY | 29.2 Million USD | 8.69% |
| 2014 Q1 | 7.04 Million USD | 8.65% |
| 2014 Q3 | 7.7 Million USD | 0.13% |
| 2014 Q4 | 6.76 Million USD | -12.23% |
| 2014 Q2 | 7.69 Million USD | 9.22% |
| 2013 Q4 | 6.48 Million USD | -8.1% |
| 2013 Q1 | 6.43 Million USD | 13.68% |
| 2013 Q3 | 7.05 Million USD | 2.27% |
| 2013 Q2 | 6.89 Million USD | 7.25% |
| 2013 FY | 26.87 Million USD | 6.53% |
| 2012 Q3 | 6.45 Million USD | -5.86% |
| 2012 Q2 | 6.86 Million USD | 9.9% |
| 2012 Q1 | 6.24 Million USD | 12.56% |
| 2012 FY | 25.22 Million USD | 4.71% |
| 2012 Q4 | 5.65 Million USD | -12.41% |
| 2011 Q3 | 6.31 Million USD | 1.4% |
| 2011 Q4 | 5.54 Million USD | -12.16% |
| 2011 Q1 | 5.99 Million USD | 17.27% |
| 2011 FY | 24.08 Million USD | 19.8% |
| 2011 Q2 | 6.22 Million USD | 3.8% |
| 2010 Q1 | 4.46 Million USD | 4.52% |
| 2010 Q4 | 5.11 Million USD | 0.2% |
| 2010 Q3 | 5.1 Million USD | -5.83% |
| 2010 FY | 20.1 Million USD | 18.6% |
| 2010 Q2 | 5.42 Million USD | 21.46% |
| 2009 FY | 16.95 Million USD | -26.12% |
| 2009 Q4 | 4.27 Million USD | -8.53% |
| 2009 Q3 | 4.66 Million USD | 18.68% |
| 2009 Q2 | 3.93 Million USD | -3.53% |
| 2009 Q1 | 4.07 Million USD | -15.45% |
| 2008 Q4 | 4.82 Million USD | -22.25% |
| 2008 Q2 | 6.21 Million USD | 8.79% |
| 2008 Q1 | 5.7 Million USD | -3.1% |
| 2008 FY | 22.94 Million USD | -6.59% |
| 2008 Q3 | 6.2 Million USD | -0.1% |
| 2007 Q1 | 5.71 Million USD | -1.39% |
| 2007 Q2 | 6.49 Million USD | 13.66% |
| 2007 Q3 | 6.46 Million USD | -0.52% |
| 2007 Q4 | 5.89 Million USD | -8.85% |
| 2007 FY | 24.56 Million USD | 4.88% |
| 2006 Q1 | 5.06 Million USD | -0.31% |
| 2006 Q4 | 5.79 Million USD | -9.14% |
| 2006 FY | 23.42 Million USD | 9.52% |
| 2006 Q3 | 6.37 Million USD | 3.21% |
| 2006 Q2 | 6.18 Million USD | 22.0% |
| 2005 Q3 | 5.35 Million USD | -4.67% |
| 2005 FY | 21.38 Million USD | 12.94% |
| 2005 Q4 | 5.08 Million USD | -5.06% |
| 2005 Q2 | 5.61 Million USD | 5.2% |
| 2005 Q1 | 5.33 Million USD | 16.95% |
| 2004 Q4 | 4.56 Million USD | -6.29% |
| 2004 FY | 18.93 Million USD | 18.39% |
| 2004 Q3 | 4.87 Million USD | -8.92% |
| 2004 Q2 | 5.34 Million USD | 28.66% |
| 2004 Q1 | 4.15 Million USD | 6.43% |
| 2003 Q4 | 3.9 Million USD | -6.27% |
| 2003 FY | 15.99 Million USD | -0.45% |
| 2003 Q3 | 4.16 Million USD | -2.36% |
| 2003 Q1 | 3.65 Million USD | 8.79% |
| 2003 Q2 | 4.26 Million USD | 16.66% |
| 2002 Q4 | 3.36 Million USD | -22.62% |
| 2002 Q1 | 3.56 Million USD | 11.79% |
| 2002 FY | 16.06 Million USD | 2.15% |
| 2002 Q2 | 4.79 Million USD | 34.31% |
| 2002 Q3 | 4.34 Million USD | -9.35% |
| 2001 Q4 | 3.19 Million USD | -19.29% |
| 2001 Q3 | 3.95 Million USD | -12.47% |
| 2001 FY | 15.73 Million USD | -18.16% |
| 2001 Q1 | 4.06 Million USD | 0.51% |
| 2001 Q2 | 4.51 Million USD | 11.17% |
| 2000 Q4 | 4.04 Million USD | -19.47% |
| 2000 Q2 | 5.47 Million USD | 16.89% |
| 2000 FY | 19.21 Million USD | -1.94% |
| 2000 Q1 | 4.68 Million USD | 11.48% |
| 2000 Q3 | 5.02 Million USD | -8.25% |
| 1999 Q1 | 4.7 Million USD | 11.9% |
| 1999 Q2 | 5.9 Million USD | 25.53% |
| 1999 Q3 | 4.9 Million USD | -16.95% |
| 1999 Q4 | 4.2 Million USD | -14.29% |
| 1999 FY | 19.6 Million USD | 10.73% |
| 1998 Q4 | 4.2 Million USD | -8.7% |
| 1998 Q1 | 4.1 Million USD | 0.0% |
| 1998 Q2 | 4.8 Million USD | 17.07% |
| 1998 FY | 17.7 Million USD | 14.94% |
| 1998 Q3 | 4.6 Million USD | -4.17% |
| 1997 Q1 | 3.3 Million USD | 3.13% |
| 1997 FY | 15.4 Million USD | 26.23% |
| 1997 Q2 | 4.4 Million USD | 33.33% |
| 1997 Q4 | 4.1 Million USD | 10.81% |
| 1997 Q3 | 3.7 Million USD | -15.91% |
| 1996 Q1 | 2.7 Million USD | 12.5% |
| 1996 FY | 12.2 Million USD | 20.79% |
| 1996 Q4 | 3.2 Million USD | 3.23% |
| 1996 Q3 | 3.1 Million USD | 0.0% |
| 1996 Q2 | 3.1 Million USD | 14.81% |
| 1995 Q2 | 2.7 Million USD | 17.39% |
| 1995 Q4 | 2.4 Million USD | -11.11% |
| 1995 Q3 | 2.7 Million USD | 0.0% |
| 1995 Q1 | 2.3 Million USD | 0.0% |
| 1995 FY | 10.1 Million USD | 16.09% |
| 1994 Q3 | 2.5 Million USD | 8.7% |
| 1994 Q4 | 2.3 Million USD | -8.0% |
| 1994 FY | 8.7 Million USD | 31.82% |
| 1994 Q2 | 2.3 Million USD | 53.33% |
| 1994 Q1 | 1.5 Million USD | -28.57% |
| 1993 Q1 | 1.1 Million USD | 0.0% |
| 1993 Q2 | 1.7 Million USD | 54.55% |
| 1993 Q3 | 1.7 Million USD | 0.0% |
| 1993 Q4 | 2.1 Million USD | 23.53% |
| 1993 FY | 6.6 Million USD | 65.0% |
| 1992 FY | 4 Million USD | 60.0% |
| 1992 Q3 | 1.2 Million USD | 20.0% |
| 1992 Q2 | 1 Million USD | 42.86% |
| 1992 Q1 | 700 Thousand USD | 0.0% |
| 1992 Q4 | 1.1 Million USD | -8.33% |
| 1991 FY | 2.5 Million USD | 47.06% |
| 1991 Q3 | 700 Thousand USD | 16.67% |
| 1991 Q4 | 700 Thousand USD | 0.0% |
| 1991 Q2 | 600 Thousand USD | 20.0% |
| 1991 Q1 | 500 Thousand USD | -16.67% |
| 1990 Q3 | 600 Thousand USD | 50.0% |
| 1990 Q2 | 400 Thousand USD | 100.0% |
| 1990 FY | 1.7 Million USD | 466.67% |
| 1990 Q1 | 200 Thousand USD | 0.0% |
| 1990 Q4 | 600 Thousand USD | 0.0% |
| 1989 Q2 | 100 Thousand USD | -66.67% |
| 1989 Q3 | 100 Thousand USD | 0.0% |
| 1989 FY | 300 Thousand USD | 200.0% |
| 1989 Q1 | 300 Thousand USD | 50.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 31.24 Million USD | 29.284% |
| Applied DNA Sciences, Inc. | 13.36 Million USD | -65.312% |
| Aspira Women's Health Inc. | 9.15 Million USD | -141.403% |
| Biodesix, Inc. | 49.08 Million USD | 54.982% |
| BioNexus Gene Lab Corp. | 9.77 Million USD | -126.164% |
| bioAffinity Technologies, Inc. | 2.53 Million USD | -772.577% |
| bioAffinity Technologies, Inc. | 2.53 Million USD | -772.577% |
| Bionano Genomics, Inc. | 36.11 Million USD | 38.814% |
| CareDx, Inc | 280.32 Million USD | 92.117% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Castle Biosciences, Inc. | 219.78 Million USD | 89.946% |
| DarioHealth Corp. | 20.35 Million USD | -8.579% |
| Exact Sciences Corporation | 2.49 Billion USD | 99.116% |
| Fulgent Genetics, Inc. | 289.21 Million USD | 92.359% |
| Guardant Health, Inc. | 563.94 Million USD | 96.082% |
| ICON Public Limited Company | 8.12 Billion USD | 99.728% |
| IDEXX Laboratories, Inc. | 3.66 Billion USD | 99.396% |
| Illumina, Inc. | 4.5 Billion USD | 99.509% |
| Intelligent Bio Solutions Inc. | 3.11 Million USD | -610.14% |
| iSpecimen Inc. | 9.92 Million USD | -122.578% |
| Standard BioTools Inc. | 106.34 Million USD | 79.219% |
| MDxHealth SA | 70.19 Million USD | 68.518% |
| 23andMe Holding Co. | 219.63 Million USD | 89.939% |
| Medpace Holdings, Inc. | 1.88 Billion USD | 98.828% |
| Myriad Genetics, Inc. | 678.4 Million USD | 96.743% |
| Mainz Biomed B.V. | 895.47 Thousand USD | -2367.73% |
| ENDRA Life Sciences Inc. | - USD | -Infinity% |
| NeoGenomics, Inc. | 591.64 Million USD | 96.265% |
| Neogen Corporation | 924.22 Million USD | 97.609% |
| Inotiv, Inc. | 572.42 Million USD | 96.14% |
| Natera, Inc. | 1.08 Billion USD | 97.959% |
| OPKO Health, Inc. | 863.49 Million USD | 97.441% |
| Prenetics Global Limited | 21.74 Million USD | -1.634% |
| Prenetics Global Limited | 21.74 Million USD | -1.634% |
| Precipio, Inc. | 15.19 Million USD | -45.41% |
| Personalis, Inc. | 73.48 Million USD | 69.927% |
| RadNet, Inc. | 1.61 Billion USD | 98.633% |
| Sera Prognostics, Inc. | 306 Thousand USD | -7121.569% |
| Sotera Health Company | 1.04 Billion USD | 97.894% |
| Neuronetics, Inc. | 71.34 Million USD | 69.028% |
| Star Equity Holdings, Inc. | 45.78 Million USD | 51.735% |
| Star Equity Holdings, Inc. | 45.78 Million USD | 51.735% |
| Trinity Biotech plc | 56.83 Million USD | 61.117% |
| Twist Bioscience Corporation | 312.97 Million USD | 92.939% |
| Exagen Inc. | 52.54 Million USD | 57.947% |